Management of Severe Asthma in 2020
An Immersive Virtual Simulation Program
Sunday, October 18, 2020 | 11:15 AM – 12:15 PM CDT
    LIVE Virtual Symposium

    Participants can access this live virtual event on Sunday, October 18, from 11:15 AM – 12:15 PM CDT.

    Activity Overview

    Severe asthma, which affects approximately 5% to 10% of patients with asthma, is associated with increased risk of hospitalization from exacerbations, increased morbidity, and increased mortality. A greater understanding of type‐2 cytokine pathways driving asthma has enabled the development of biomarkers and identification of therapeutic targets. By better identifying asthma phenotypes and endotypes, drugs targeting specific cytokines can be used to achieve asthma control and reduce the burden of disease for patients with refractory symptoms despite standard treatment.

    This Medscape virtual symposium will bring a patient case to life using an award-winning Virtual Patient Simulation platform, MedSims. During the virtual symposium, attendees will be uniquely engaged in the MedSims and be able to contribute to the direction of the patient journey at key decision points and vote on clinical actions followed by expert faculty feedback. This will help provide evidence-based management of patients with asthma through the identification of phenotypic profile and comorbidities, determination of severity and level of control, and selection of appropriate biologic therapy.

    • Mario Castro, MD, MPH
      Division Chief
      Pulmonary, Critical Care and Sleep Medicine
      Vice Chair for Clinical and Translational Research
      Director of the Rainbow Clinical Trials Science Unit, Frontiers
      University of Kansas School of Medicine
      Kansas City, Kansas
    • Jonathan Corren, MD
      Associate Clinical Professor of Medicine and Pediatrics
      David Geffen School of Medicine at UCLA
      University of California, Los Angeles
      Los Angeles, California
    • Nicola Hanania, MD
      Associate Professor of Pulmonary Medicine
      Airways Clinical Research Center
      Baylor College of Medicine
      Houston, Texas
    Program Sunday, October 18, 2020
    • 11:15 AM
    • Introduction
    • 11:20 AM
    • Setting the stage: Current treatment paradigm for patients with severe asthma
    • 11:25 AM
    • Virtual patient case challenge, audience participation, and evidence-based discussion
    • 12:05 PM
    • Q&A
    Learning Objectives
    • Demonstrate improved performance associated with
      • Ordering tests to identify phenotypic profile and comorbidities in patients with asthma
      • Evaluating patients with asthma to determine severity and level of control
      • Selecting appropriate biologic therapy for asthma based on phenotypic profile, comorbidities, and severity
    Target Audience
    Goal Statement
    Credits Available
    • 1.0
    • For Physicians
    Accreditation Statement
    Your home!
    Supported by an independent educational grant from
    Sanofi Genzyme and Regeneron Pharmaceuticals.